Relafen 750, featuring naproxen sodium, presents a intriguing case from a biochemical perspective. Its mechanism of action involves inhibiting cyclooxygenase (COX) enzymes, specifically COX-2, which leads to a decrease of prostaglandin formation. This biochemical process directly affects inflammation and pain perception, highlighting its role as a